Phosphoramidon, a novel matrix metalloproteinase inhibitor, inhibits significantly tumor growth independently of the application route (intraperitoneal [i.p.] versus intravenous [i.v.]) in a rat model of peritoneal carcinomatosis
2018 ◽
Vol 366
(1)
◽
pp. 194-204
◽
2005 ◽
Vol 4
(11)
◽
pp. 1717-1728
◽
2004 ◽
Vol 20
(3)
◽
pp. 217-236
◽
2015 ◽
Vol 9
(5)
◽
pp. 1813-1818
◽